Ventricular ectopy in cardiac rehabilitation patients on exercise training and nonexercising days.

Clinical Cardiology
D L Lillis, P Hanson

Abstract

We evaluated the effect of routine exercise training sessions on the frequency of ventricular ectopic activity (VEA) in 18 coronary artery disease patients (mean age = 60 years) who were active participants in a cardiac rehabilitation program. Nine patients were classified as high risk and nine patients were low risk according to clinical status and cardiac catheterization criteria. Five patients in each group were on beta blockade, but none were on antiarrhythmic agents. Serial 24-h ECG monitoring was obtained on a routine supervised exercise day and nonexercise control day. VEA were compared during three time periods: (1) exercise training and recovery (4 h) and the corresponding 4 h during control, (2) activities of daily living (12 h), and (3) sleep (8 h). Both groups showed a moderate increase in total VEA during the three activity periods from control day to exercise day. However, this increase was only significant (p less than 0.05) in the high-risk group during the 12-h activity of daily living period postexercise. VEA was significantly greater (p less than 0.05) in the high-risk group during all activity intervals except the sleep period on the exercise day. We conclude that VEA occurs with similar frequency during exe...Continue Reading

References

Feb 1, 1979·The American Journal of Cardiology·B Lown
Sep 1, 1978·The American Journal of Cardiology·J D CookseyP E Cryer
Jan 1, 1979·The American Journal of Cardiology·B EkblomW C Day
Aug 1, 1976·Journal of Chronic Diseases·W RubermanC L Feldman
Dec 1, 1987·The American Journal of Cardiology·J E Schauer, P Hanson
Jul 1, 1971·Circulation·B Lown, M Wolf
Oct 18, 1969·British Medical Journal·P TaggartW Somerville
Oct 4, 1984·The New England Journal of Medicine·D S SiscovickT Lasky
Jan 1, 1983·Medicine and Science in Sports and Exercise·R P DolatowskiD H Schmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.